Social support of autonomy tied to better glycemic control in DM

April 18, 2018

(HealthDay)—Family and friends' autonomy support may lead to better glycemic control by reducing distress among patients with diabetes, according to a study published online March 29 in Diabetes Care.

Aaron A. Lee, Ph.D., from the VA Center for Clinical Management Research in Ann Arbor, Mich., and colleagues surveyed 308 veterans with type 2 diabetes and one or more risk factors for to assess diabetes distress and perceived autonomy support from their main informal health supporter. Electronic medical records were used to access hemoglobin A1c (HbA1c) data from 12 months before and after the survey.

The researchers found that diabetes distress (P = 0.023) was associated with higher, and autonomy support (P = 0.032) with lower, subsequent HbA1c levels. The relationship between diabetes distress and HbA1c (P = 0.027) was moderated by autonomy support. With low autonomy support, greater diabetes distress was associated with higher HbA1c (P = 0.002), but not with high autonomy support (P = 0.890).

"Autonomy support from main health supporters may contribute to better glycemic control by ameliorating the effects of diabetes distress," the authors write. "Interventions that reduce distress and enhance the autonomy supportiveness of informal supporters may be effective approaches to improving glycemic control."

Explore further: Food insecurity tied to poor glycemic control in diabetes

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Food insecurity tied to poor glycemic control in diabetes

March 23, 2018
(HealthDay)—Limited food access owing to cost (food insecurity) is associated with increased hemoglobin A1c (HbA1C) among patients with diabetes, according to a study published online March 19 in Diabetes Care.

Diabetes, HbA1c linked to adverse outcomes after surgery

April 3, 2018
(HealthDay)—For surgical inpatients aged ≥54 years, diabetes and increased hemoglobin A1c (HbA1c) are associated with increased risk of adverse outcomes, according to a study published online March 26 in Diabetes Care.

Ertugliflozin tied to improved glycemic control in T2DM

February 20, 2018
(HealthDay)—For adults with inadequately controlled type 2 diabetes, ertugliflozin treatment is associated with improved glycemic control over 52 weeks, according to a study published online Feb. 8 in Diabetes, Obesity ...

Diabetes-related distress ups risk for rx nonadherence

October 31, 2016
(HealthDay)—Diabetes-related distress and depression symptom severity are risk factors for medication nonadherence in type 2 diabetes, according to a study published online Oct. 17 in Diabetes Care.

Disordered eating associated with higher HbA1c in teens

January 31, 2018
(HealthDay)—For youth with type 1 diabetes, disordered eating behaviors (DEBs) are associated with higher hemoglobin A1c but not with measures of glycemic variability, according to a study published online Jan. 25 in Diabetes ...

Fasting plasma glucose, HbA1c linked to alzheimer's in T2DM

July 25, 2017
(HealthDay)—For patients with type 2 diabetes mellitus (T2DM), fasting plasma glucose (FPG) visit-to-visit variation, represented by the coefficient of variation (CV), and hemoglobin A1c (HbA1c) CV are independently associated ...

Recommended for you

Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes

December 11, 2018
Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes.

Millions of low-risk people with diabetes may be testing their blood sugar too often

December 10, 2018
For people with Type 2 diabetes, the task of testing their blood sugar with a fingertip prick and a drop of blood on a special strip of paper becomes part of everyday life.

Very low calorie diets trialled by NHS to tackle diabetes

December 7, 2018
Hundreds of thousands of people will receive NHS help to battle obesity and type 2 diabetes under radical action set out by Simon Stevens, Chief Executive of NHS England.

New therapeutic avenue for type 2 diabetes

December 6, 2018
Restoring the action of insulin is one of the keys to fighting type 2 diabetes. Researchers from Inserm led by Dominique Langin at the Institute of Cardiovascular and Metabolic Diseases (Inserm/Université de Toulouse) are ...

Subtype of immune B cells can delay type 1 diabetes onset in mice

December 6, 2018
A team of researchers at Baylor College of Medicine and the University of Michigan Medical School reports today in the JCI Insight that a subset of immune B cells, known as CD19+IgM+ B cells, can delay the onset of type 1 ...

Is the pancreas regeneration debate settled? An original theory renewed

December 5, 2018
A contentious debate among diabetes researchers has surrounded the regeneration of pancreatic insulin-producing cells: not if these cells regenerate, but rather how.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.